When was Terrestrial founded?

Terrestrial was founded in 2011 and raised its 1st funding round 15 years after it was founded.

Where is Terrestrial located?

Terrestrial is headquartered in Woburn, United States.

How many employees does Terrestrial have?

As of Mar 31, 2026, the latest employee count at Terrestrial is 76.

Is Terrestrial a funded company?

Terrestrial is a funded company, having raised a total of $***** in its 1st and only funding round, a Series C round on Mar 04, 2026.

When was the latest funding round of Terrestrial?

Terrestrial's latest funding was a $***** Series C round on Mar 04, 2026, with participation from 4 investors. Its primary sector is Drug Delivery. In United States, the Drug Delivery sector has seen $240M in funding in 2026 to date.

Where does Terrestrial rank among its competitors?

Terrestrial ranks 4th amongst 26 active competitors, of which 9 are funded. It stands 4th in terms of total funding among its competitors. The most recent competitor to raise funding was Terrestrial, which secured $57.3M in Mar, 2026.

Who are the top competitors of Terrestrial?

Terrestrial's top competitors include Insulet, Micron Biomedical and Enable Injections. Among them, Terrestrial secured the most recent funding round in March, 2026.

Terrestrial - 2026 Company Profile, Funding & Competitors

Terrestrial is a series C company based in Woburn (United States), founded in 2011. It operates as a Developer of a microarray patch platform for therapeutic delivery. Terrestrial has raised $57.3M in funding from RA Capital Management. The company has 26 active competitors, including 9 funded and 3 that have exited. Its top competitors include companies like Insulet, Micron Biomedical and Enable Injections.

Company Details

Developer of a microarray patch platform for therapeutic delivery. The platform uses dissolvable tips made from advanced biomaterials for dose delivery and control. It aims to transform the delivery of therapies, offering a more convenient and comfortable patient experience. The platform seeks to eliminate the need for needles and refrigeration.

Website: www.terrestrialbio.com/
Email ID: *****@terrestrialbio.com

Key Metrics

Founded Year

2011

Location

Woburn, United States

Stage

Series C

Total Funding

$57.3M in 1 round

Latest Funding Round

Series C, Mar 04, 2026, $*****

Investors

RA Capital Management & 3 more

Ranked

4^th among 26 active competitors

Employee Count

76 as on Mar 31, 2026

Similar Companies

Insulet & 25 more

View Terrestrial's full profile

Terrestrial has raised a total funding of $57.3M over 1 round. Its latest funding round was a Series C round on Mar 04, 2026 for $*****. 4 investors participated in its latest round. Terrestrial has 4 institutional investors.

Here is the list of recent funding rounds of Terrestrial:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Mar 04, 2026	6097439	Series C	2838226	5889373	6037104	9710215

Access funding benchmarks and valuations. Sign up today!

View details of Terrestrial's funding rounds and investors

Terrestrial's employee count trend

Terrestrial has 76 employees as of Mar 26. Here is Terrestrial's employee count trend over the years:

Uncover Terrestrial's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Terrestrial include Insulet, Micron Biomedical and Enable Injections. Here is the list of Top 10 competitors of Terrestrial, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Insulet 2000, Boston (United States), Public	Manufacturer of wearable, tubeless insulin delivery systems for diabetes management	$120M	Federated Hermes, Piper Jaffray & 13 others	74/100
2nd	Micron Biomedical 2014, Atlanta (United States), Series A	Developer of microneedle patch technology for vaccines and drugs delivery	$33M	J2 Ventures, Global Health Investment & 10 others	60/100
3rd	Enable Injections 2010, Cincinnati (United States), Series C	Provider of a wearable drug delivery solution	$334M	Sanofi, Magnetar & 13 others	59/100
4th	Terrestrial 2011, Woburn (United States), Series C	Developer of a microarray patch platform for therapeutic delivery	$57.3M	RA Capital Management, Engine Ventures & 2 others	39/100
5th	Zosano Pharma 2006, Fremont (United States), Deadpooled	Developer of transdermal drug delivery systems for a broad range of therapeutic indications	$147M	Nomura, ProQuest Investments & 9 others	36/100
6th	SkinJect 2015, Pittsburgh (United States), Series A	Developer of microneedle patch to treat skin cancer	$2.5M	Topanga Partners, Velocity Fund Partners	34/100
7th	Array Patch 2019, Dublin (Ireland), Seed	Developer of microneedle patch technology for targeted drug delivery applications	$1.9M	Lakesidecapital, Boole Angel Investment Syndicate ... & 1 others	33/100
8th	Raphas 2006, Seoul (South Korea), Public	Developer of microneedle technology for cosmetics and medical applications	-	NHN Investment, Shinhan Venture Investment ... & 5 others	33/100
9th	Innovodigm 2018, Kolkata (India), Seed	Developer of vaccine delivery devices	$635K	Indian Angel Network, BIRAC & 1 others	32/100
10th	OBaris 2024, Schlieren (Switzerland), Acquired	Developer of a needle-free, self-applicable transdermal patch for injectables	-	-	31/100